Outcome
The patient started on rosuvastatin 10 mg once a day and fenofibrate 145 mg once a day. The patient’s xanthomas improved dramatically within a month (FIGURES 3 AND 4). His cholesterol, on the therapy described above, improved dramatically. His triglycerides decreased to 363 mg/dL. His total cholesterol was now 138 mg/dL, with an HDL of 34 mg/dL and an LDL of 31 mg/dL.
FIGURE 3
After treatment
FIGURE 4
Close-up
The patient reported no adverse effects from the medications. It was recommended that he continue on his present therapy indefinitely with the proper laboratory follow-up. We have not increased his dose of either medication, since his admission and no side effects have been encountered. We will continue to monitor his liver function tests and adjust the dose of his medications as needed.
CORRESPONDENCE
Jay Shubrook, DO, Parks Hall, Ohio University College of Medicine, Athens, OH 45701.